The human microbiome, a diverse community of microorganisms vital for digestion, immunity, and metabolism, is emerging as a powerful target for therapeutic intervention. This chapter examines the burgeoning field of microbiome-driven therapies, particularly focusing on the microbiome’s impact on health and its role in personalized medicine. We explore how microbial imbalances contribute to diseases like inflammatory bowel disease (IBD), metabolic disorders, neurological conditions, and cancer, and discuss the latest advancements in therapeutic strategies. These include probiotics, prebiotics, fecal microbiota transplantation (FMT), and microbial-based drugs, while also acknowledging the challenges of clinical translation. Furthermore, we highlight the integration of microbiome profiling and metagenomic analysis in advancing precision medicine, enabling tailored treatments based on individual microbial signatures. This chapter aims to provide a comprehensive overview of current knowledge, address research gaps, and outline future directions in microbiome-based therapies, offering a valuable resource for clinicians, researchers, and policymakers seeking to leverage the microbiome for improved healthcare outcomes.